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Objective: To assess the clinical outcomes of laparoscopic comprehensive staging surgery in early stage
ovarian cancer.
Materials and methods: Electronic literature searches were conducted in Embase, MEDLINE, Cochrane
Library, China Biology Medicine, and Chinese National Knowledge Infrastructure, and literature on lap-
aroscopy versus laparotomy for comprehensive staging surgery was retrieved. The literature was selected
according to certain inclusion criteria. Data were extracted from these studies and the quality of the
included studies was assessed. The meta-analysis was conducted using the ReviewManager 5.2 software.
Results: A total of 11 nonrandomized controlled trials involving 591 cases were included. The pooled data
indicated less intraoperative blood loss, lower postoperative complication rates, shorter postoperative
hospital stays, and lower postoperative recurrence rates in the laparoscopy group. There were no sig-
niﬁcant differences in operative time, harvested lymph node number, intraoperative complications, or
mortality.
Conclusion: For comprehensive staging surgery, laparoscopy was equivalent to or even better than
conventional laparotomy for early ovarian cancer. More robust evidence should be explored for precise
veriﬁcation.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Ovarian cancer represents 2.4e5.6% of all female malignancies
and has the highest mortality rate for women who develop gyne-
cologic malignancies [1,2]. Women with advanced ovarian cancer
have a 5-year survival rate of <50%, but those with Stage I ovarian
cancer have a 5-year survival rate of 85e90% [3]. However, in
clinical practice, Stage I ovarian cancer is usually found incidentally
during routine ultrasonography, laparoscopy, or laparotomy for an
ovarian cyst or presumed benign tumors [4,5]. Furthermore, for
patients with Stage I ovarian cancer, >30% are upstaged after
comprehensive surgical staging because of microscopic metastatic
disease [2,6].
According to the International Federation of Gynecology and
Obstetrics (FIGO), standard management for apparent early stage
disease is complete surgical staging, including total abdominalynecology, Cancer Hospital of
530021, China.
ao).
bstetrics & Gynecology. Publishedhysterectomy, bilateral salpingo-oophorectomy, pelvic and para-
aortic lymph node dissection, infracolic omentectomy, multiple
peritoneal washing, and multiple peritoneal biopsies during a
generous laparotomy [2]. The FIGO guidelines indicated that there
are three independent factors affecting the survival of all patients
with ovarian cancers: stage of cancer at diagnosis, histological
grade, and volume of residual disease after surgery [7]. Thus, it is of
signiﬁcant importance to stage early stage ovarian cancer (EOC) to
predict patients' prognosis adequately. Furthermore, staging in-
formation is a crucial factor for deciding the appropriate adjuvant
therapy for most gynecologic oncologists [4]; in addition, fertility
sparing treatmentmay be appropriately offered to youngwomen as
requested if Stage I disease is conﬁrmed [6].
The conventional approach for ovarian cancer is surgical
exploration through a midline vertical abdominal incision [4].
However, recent developments in laparoscopy for staging provide
an attractive option for optimal surgical and oncologic outcomes,
although the cost of laparoscopy is higher than that of laparotomy
[4]. The feasibility, safety, and advantages of laparoscopic staging
surgery for ovarian cancer are well established [2,4]. The advan-
tages of laparoscopy over laparotomy are better intraoperativeby Elsevier Taiwan LLC. All rights reserved.
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operative complications such as wound infections and small bowel
ileus, a shorter hospital stay, and a faster recovery [8e10].
However, laparoscopic staging surgery for EOC is not without
controversy, and only a few studies are available to help elucidate
whether laparoscopy is a proper management tool for EOC because
of difﬁculty in recruiting a sufﬁcient number of patients [4]. Con-
cerns over minimally invasive surgery for EOC are the carbon di-
oxide effect, dissemination occurring from the exfoliation of tumor
cells, and a high risk of intraoperative tumor rupture due to limi-
tations in laparoscopic staging surgery [4,11]. Because of recent
advances in laparoscopic techniques and instruments, early con-
cerns have been largely unfounded [10,12]. As evidence is gradually
accumulated, laparoscopic staging of EOC has at least equivalent,
although not signiﬁcantly superior, surgicalepathological out-
comes and middle-range oncologic results as a conventional
treatment approach [10]. No vital evidence exists to determine the
efﬁcacy and safety of laparoscopic surgery versus laparotomy for
staging EOC, and only a descriptive systematic review [9] and a
quantitative meta-analysis [12] involving no Chinese populations
were available. Therefore, we aimed to conduct a meta-analysis of
laparoscopic comprehensive staging surgery for patients with EOC.
Materials and methods
Literature search
A thorough literature search was performed by two indepen-
dent researchers using the key words “ovarian cancer”, “early
stage”, “laparoscopy”, “staging surgery”, and “staging laparoscopy”
in MEDLINE (from December 1969), Embase (from September
1974), the Cochrane Library (from February 1990), China Biology
Medicine (from 1987), and Chinese National Knowledge Infra-
structure (from 1999) for all articles published (to March 2014).
Abstracts of trials that were identiﬁed through electronic searches
were further reviewed, and those with original data that specif-
ically provided useful operative outcomes were retrieved for
detailed evaluation.
Study selection
The inclusion criteria for studies that were subject to our meta-
analysis were as follows: (1) study design: randomized controlled
trials (RCTs) or well-designed nonrandomized controlled trials with
no conﬁnement on allocation concealment, blinding, or districts;
(2) patients: individuals diagnosed with EOC; (3) intervention: the
experimental group had laparoscopic staging surgery, and the
control group had a laparotomy; and (4) outcomes: operative time,
intraoperative blood loss, time to ﬁrst postoperative ﬂatus, number
of resected pelvic lymph nodes, intraoperative or postoperative
complication rate, recurrence rate, etc.
The exclusion criteria were as follows: (1) comments, reviews,
and editorials; (2) incomplete original data or studies with only
abstracts available; (3) case reports, case series, and noncontrolled
researches; (4) studies in which laparoscopic surgery was per-
formed for diagnostic biopsy instead of radical treatment; and (5)
overlapping articles, and in cases of duplicate study populations,
only the larger study was included in our analysis.
Data extraction
Two independent researchers reviewed the literature by strictly
following the inclusion/exclusion criteria. After analyzing each
study, the following variables showing operative outcomes were
examined: (1) operation time [mean ± standard deviation (SD),minutes]; (2) intraoperative blood loss (mean ± SD, mL); (3) pelvic
lymphadenectomy number; (4) para-aortic lymphadenectomy
number; (5) time to ﬁrst postoperative ﬂatus; (6) intraoperative
complications; (7) postoperative complications; (8) hospital stays;
(9) recurrence rate during follow-up after staging surgery; (10)
postoperative mortality rate; and (11) rate of intraoperative tumor
rupture. While examining these variables, data presented as a
median value and a range were converted to a mean value and SD
using the formula proposed by Hozo et al [13].
Methodological quality assessment
Two authors independently assessed the risk of bias according to
the Cochrane Handbook for Systematic Reviews of Interventions [14].
We evaluated the risk of bias in the included studies using the Re-
view Manager software (RevMan version 5.2; The Nordic Cochrane
Center, The Cochrane Collaboration, Copenhagen, Denmark), which
included the following key domains: (1) sequence generation; (2)
allocation sequence concealment; (3) blinding; (4) incomplete
outcome data; (5) selective outcome reporting; and (6) other po-
tential sources of bias.
Data analysis
The analysis was performed using RevMan version 5.2 (The
Nordic Cochrane Center). The c2 test was used to assess heteroge-
neity. A p value <0.10 was considered statistically signiﬁcant. The
I2 statistic was used to estimate the degree of heterogeneity.
Dichotomous data are presented as relative risks with 95% conﬁ-
dence intervals (CIs). We analyzed the data based on an intention-
to-treat principle. If no heterogeneity was detected, a ﬁxed effects
model was used to analyze the data. A random effects model was
used if therewas any unexplained heterogeneity. The authors of the
included studies were contacted to supply any missing data. If a
sufﬁcient number of eligible trials (>10 studies) existed, a funnel
plot analysis was conducted to assess reporting biases [15]. We
conducted a subgroup analysis to test for differences between re-
sults published in English and Chinese.
Results
A total of 565 potentially relevant studies regarding laparoscopic
comprehensive staging surgery and EOC were identiﬁed, among
which 432 studies were in English, and the remaining 133 studies
were in Chinese. Five hundred and thirty-two studies were initially
excluded for various reasons: 481 irrelevant studies were excluded
after reviewing the titles and abstracts; a few other studies were
excluded because they were case reports (n ¼ 5), reviews (n ¼ 6),
and duplicates (n ¼ 40). After reviewing and analyzing the clinical
outcomes of the initially selected studies, only 11 trials with 591
EOC patients were identiﬁed that satisﬁed the inclusion/exclusion
criteria, of which ﬁve studies were published in English and six
studies were published in Chinese (Fig. 1). The methodological
quality of the included trials is presented in Fig. 2.
The included 11 studies [2,4,16e24] involved 591 participants
and were all nonrandomized controlled trials comparing laparos-
copy with laparotomy for the staging of EOC patients. The baseline
characteristics of all 591 EOC patients are summarized in Table 1.
There were 235 patients in the laparoscopy group and 356 patients
in the laparotomy group, and no statistically signiﬁcant differences
in age, body mass index, clinical staging, pathological pattern, or
histological grading were observed between the two groups.
The operative time (minutes) between the two groups was
investigated with statistical heterogeneity among the results of all
studies (I2 ¼ 77%; p < 0.00001), and therefore a random effect
Fig. 1. A ﬂowchart of the study selection.
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difference in operative time between the laparoscopy and lapa-
rotomy groupsdmean difference (MD) ¼ 15.33; 95% CI [3.87,
34.53]; p ¼ 0.12. There were no signiﬁcant subgroup differences:
c2 ¼ 0.93; df ¼ 1 (p ¼ 0.34); and I2 ¼ 0% (Fig. 3A).
The intraoperative blood loss (mL) was analyzed in 10 included
studies [2,4,16e22, 24]. A random effect model was used to pool the
data because signiﬁcant heterogeneity was observed (I2 ¼ 91%;
p < 0.00001). There was signiﬁcance in intraoperative blood loss
[MD ¼ 1.73; 95% CI (2.41, 1.04); p < 0.00001], with reduced
intraoperative blood loss observed in the laparoscopy group. There
were signiﬁcant subgroup differences: c2 ¼ 10.45; df ¼ 1
(p ¼ 0.001); and I2 ¼ 90.4% (Fig. 3B).
The pelvic lymphadenectomy number was analyzed in nine
included studies [2,4,16,17,19,21e24]. There was no statistical het-
erogeneity in pelvic lymphadenectomy number (I2¼ 33%; p¼ 0.15),
and therefore a ﬁxed effect model was used to analyze the data. The
pooled results revealed no signiﬁcant difference in pelvic lym-
phadenectomy number between the two groups [MD¼0.91; 95%
CI (2.00, 0.17); p ¼ 0.01]. There were no signiﬁcant subgroup
differences: c2 ¼ 0.24; df ¼ 1 (p ¼ 0.62); and I2 ¼ 0% (Fig. 3C).
The para-aortic lymphadenectomy number was analyzed in
seven included studies [2,4,17,21e24]. A random effect model was
used to pool the data because statistical heterogeneity was
observed (I2 ¼ 65%; p ¼ 0.009). However, there was no signiﬁcant
difference in para-aortic lymphadenectomy number between the
two groups [MD ¼ 0.77; 95% CI (0.94, 2.48); p ¼ 0.38]. There were
no signiﬁcant subgroup differences: c2¼ 0.10; df¼ 1 (p¼ 0.76); and
I2 ¼ 0% (Fig. 3D).
The time to ﬁrst postoperative ﬂatus (days) was analyzed in nine
included studies [2,4,16e22]. There was statistical heterogeneity
regarding the time to ﬁrst postoperative ﬂatus (I2 ¼ 93%;
p < 0.00001), and therefore a random effect model was used to
analyze the data. Reduced time to ﬁrst postoperative ﬂatus wasobserved in the laparoscopy group, and there was a signiﬁcant
difference between the two groups [MD ¼ 1.28; 95% CI
(1.72, 0.83); p < 0.00001]. There were signiﬁcant subgroup
differences: c2 ¼ 27.92; df ¼ 1 (p < 0.00001); and I2 ¼ 96.4%
(Fig. 3E).
The intraoperative complications were analyzed in ﬁve included
studies [2,4,22e24]. There was no statistical heterogeneity in
intraoperative complications (I2 ¼ 0%; p ¼ 0.59), and therefore a
ﬁxed effect model was used to pool the data. No signiﬁcant dif-
ference was observed between the two groups in intraoperative
complications [odds ratio or OR¼ 1.34; 95% CI (0.37, 4.93); p¼ 0.66;
Fig. 3F].
The postoperative complications were analyzed in eight
included studies [2,4,16,17,19,21e23]. There was no statistical het-
erogeneity in postoperative complications (I2 ¼ 0%; p ¼ 0.74), and
therefore a ﬁxed effect model was used to pool the data. No sig-
niﬁcant difference was observed between the two groups in post-
operative complications [OR ¼ 0.26; 95% CI (0.13, 0.52); p ¼ 0.000].
There were no signiﬁcant subgroup differences: c2 ¼ 0.90; df ¼ 1
(p ¼ 0.34); and I2 ¼ 0% (Fig. 3G).
The hospital stay was analyzed in seven included studies
[2,4,16,20e22,24]. A random effect model was used to pool the data
because statistical heterogeneity was observed (I2 ¼ 91%;
p < 0.00001). There were reduced hospital stays in the laparoscopy
group, and there was a signiﬁcant difference between the two
groups [MD ¼ 4.87; 95% CI (7.26, 2.47); p < 0.0001]. There
were no signiﬁcant subgroup differences: c2 ¼ 0.01; df ¼ 1
(p ¼ 0.91); and I2 ¼ 0% (Fig. 3H).
The recurrence rate during the follow-up period after staging
surgery was analyzed in seven included studies [2,4,17,19,21e23]. A
ﬁxed effect model was used to pool the data because statistical
heterogeneity was observed (I2 ¼ 41%; p < 0.13). There was a
reduced recurrence rate in the laparoscopy group, and there was a
signiﬁcant difference between the two groups [OR ¼ 0.32; 95% CI
Fig. 2. A methodological quality assessment of the included studies: (A) risk of bias; (B) quality assessment.
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ences: c2 ¼ 0.60; df ¼ 1 (p ¼ 0.44); and I2 ¼ 0% (Fig. 3I).
The postoperative death rate during the follow-up period after
staging surgery was analyzed in four included studies [2,17,22,23].
A ﬁxed effect model was used to pool the data because statistical
heterogeneity was observed (I2 ¼ 0%; p ¼ 0.83). There was no sig-
niﬁcant difference between the two groups [OR ¼ 0.47; 95% CI
(0.09, 2.59); p ¼ 0.83]. There were no signiﬁcant subgroup differ-
ences: c2 ¼ 0.04; df ¼ 1 (p ¼ 0.83); and I2 ¼ 0% (Fig. 3J).Upstaging secondary to intraoperative tumor rupture was
observed in three included studies [2,4,18]. Lee et al [4] found that
the intraoperative tumor rupture rate was lower in the laparoscopy
group than in the laparotomy group, and a signiﬁcant difference
was observed (laparoscopy/laparotomy: 0/14.9%; p ¼ 0.037).
However, Park et al [2] found no signiﬁcant difference in intra-
operative tumor rupture between the two groups (laparoscopy/
laparotomy: 10.5/12.1%; p ¼ 1.00). Park et al [2] also compared the
resection volume of the greater omentum (cm3) between the two
Table 1
Clinical baseline characteristics of patients undergoing staging surgery in the included studies.
Included studies Patients (n) Year Pathological pattern
(epithelial/sex cordestromal/germ cell tumors/carcinosarcoma)
FIGO staging (I/II/IIIa)
T C T C T C T C
Yang et al (2012) [16] 29 35 42.32 ± 13.72 41.53 ± 11.24 26/1/2/0 31/2/2/0 27/2/0 31/4/0
Huang et al (2012) [17] 12 11 43.2 43.2 12/0/0/0 11/0/0/0 12/0/0 11/0/0
Li (2012) [18] 20 23 50.00 ± 9.30 51.82 ± 7.52 14/4/2/0 17/5/1/0 16/4/0 19/4/0
Zhao et al (2012) [19] 20 38 44.2 ± 12.5 48.7 ± 14.5 20/0/0/0 38/0/0/0 20/0/0 38/0/0
Chen (2011) [20] 38 36 48.5 50.2 38/0/0/0 36/0/0/0 38/0/0 36/0/0
Lee et al (2011) [4] 26 87 42.2 ± 10.8 44.4 ± 14.0 22/2/2/0 71/2/14/0 25/0/1 82/5/0
Zuo et al (2010) [21] 19 25 41.9 ± 13.7 50.8 ± 15.1 15/3/1/0 17/4/4/0 17/2/0 17/8/0
Park et al (2008) [2] 19 33 43.9 ± 9.8 45.4 ± 10.8 18/0/0/0 33/0/0/0 15/1/3 26/1/6
Park et al (2008) [22] 17 19 43.2 ± 12.3 48.9 ± 10.8 17/0/0/0 19/0/0/0 16/1/0 13/4/2
Ghezzi et al (2007) [23] 15 19 55 (13e70) 61 (44e71) 13/0/1/1 19/0/0/0 11/0/4 13/0/6
Chi et al (2005) [24] 20 30 47.3 ± 11.2 50.6 ± 11.4 17/2/1/0 30/0/0/0 20/0/0 30/0/0
FIGO ¼ International Federation of Gynecology and Obstetrics; T ¼ laparoscopy group; C ¼ laparotomy group.
a Patients were initially diagnosed with early ovarian cancer but ﬁnally identiﬁed with FIGO III after comprehensive staging surgery.
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similar results were observed [laparoscopy/laparotomy:
(159.5 ± 142.9)/(274.2 ± 289.4)] by Chi et al [24]. Both studies found
no difference in resection volume of the greater omentum between
the two groups [2,24]. The operative time was selected to analyze
the publication bias, and a funnel chart indicated a low publication
bias (Fig. 4).
Discussion
The presented meta-analysis included 11 clinical trials with 591
participants that compared the clinical outcomes of laparoscopy
with laparotomy for staging surgery. There were no signiﬁcant
differences in operative time, lymphadenectomy number, intra-
operative complications, postoperative complications, or post-
operative death rate between the two groups. However, reduced
intraoperative blood loss, time to ﬁrst ﬂatus, hospital stays, and
recurrence rate were observed in the laparoscopy group. These
pooled results indicated that the curative effect of laparoscopy for
staging surgery was at least equivalent to traditional laparotomy or
was even better considering the reduced intraoperative blood loss,
time to ﬁrst ﬂatus, hospital stay, and recurrence rate. More robust
evidence might be necessary to conﬁrm the safety and efﬁcacy of
laparoscopic staging surgery because our meta-analysis only
included 11 nonrandomized controlled trials with small samples
and short follow-ups.
Although laparoscopy involves more expenses because of the
cost of disposable instrumentation and direct material/operating
room costs, it has been commonly recognized for the following
merits: short hospital stay and detailed veriﬁcation, as well as
control of structures such as small vessels that may not be identi-
ﬁed with the naked eye [4,25]. The purpose of staging surgery for
ovarian cancer is to establish a diagnosis, to assess the extent of
disease, and to resect as much tumor as possible [9]. We compared
the feasibility and efﬁcacy of laparoscopy for staging surgery with
measurements including operating time, pelvic and para-aortic
lymph node yields, the size of the omental specimen, rupture of
ovarian tumors, etc. [9].
Some previous studies have reported signiﬁcantly longer oper-
ating times with laparoscopy [4,23,24], while other researchers
found signiﬁcantly shorter times with laparoscopy [2]. These dif-
ferences might be because of differences in surgeons' skills and
laparoscopic techniques between investigator teams. However, our
pooled data involving all 11 studies presented no signiﬁcant dif-
ference in operative time between the laparoscopy group and the
laparotomy group [MD ¼ 15.33; 95% CI (3.87, 34.53); p ¼ 0.12].
These ﬁndings might be a little different from previous studies[4,23,24]; we believe our study contributes evidence of a similar
operative time between the laparoscopy group and the laparotomy
group.
It has been reported that blood loss in the laparoscopy group
was signiﬁcantly less than that of the laparotomy group [9].
Furthermore, blood transfusion rates in laparoscopic staging sur-
gery ranged from 0% to 15%, whereas transfusions were necessary
in up to 30% of women who underwent laparotomy [9]. Our meta-
analysis also found decreased intraoperative blood loss in the lap-
aroscopy group compared with the laparotomy group, and the
difference was statistically signiﬁcant [MD ¼ 1.73; 95% CI
(2.41, 1.04); p < 0.00001].
There was an inherent shortcoming of laparoscopy for surgical
staging, as some researchers considered the inability to palpate
lymph nodes and other peritoneal surfaces [26], whereas others
argued that intraoperative direct visualization and the evaluation
of nodes by palpation were inherently subjective [9]. To evaluate
the difference in the number of harvested lymph nodes between
the laparoscopy and laparotomy groups, we analyzed the pelvic
lymphadenectomy number in nine included studies, and the para-
aortic lymphadenectomy number was analyzed in seven included
studies. Our pooled results revealed no signiﬁcant difference in
pelvic lymphadenectomy number between the two groups
[MD ¼ 0.91; 95% CI (2.00, 0.17); p ¼ 0.01; Fig. 3C], and no sig-
niﬁcant difference in para-aortic lymphadenectomy number be-
tween the two groups [MD ¼ 0.77; 95% CI (0.94, 2.48); p ¼ 0.38].
These operative outcomes suggested that staging surgery using a
laparoscopic approach to remove lymph nodes might have an
equivalent efﬁcacy as open surgery.
Intraoperative ovarian tumor rupture has been reported to occur
more frequently with laparoscopy thanwith laparotomy [27], and it
has been identiﬁed as a prognostic indicator of disease-free survival
[28]. One of our included studies [4] indicated a lower intra-
operative tumor rupture rate in the laparoscopy group than in the
laparotomy group, and a signiﬁcant difference was observed (lap-
aroscopy/laparotomy: 0/14.9%; p ¼ 0.037). Another study [2] found
no signiﬁcant difference in intraoperative tumor rupture between
the two groups (laparoscopy/laparotomy: 10.5/12.1%; p ¼ 1.00).
There were no sufﬁcient studies to pool the data, but the available
data suggested that the intraoperative tumor rupture rate with
laparoscopy might be lower than or at least similar to that of lap-
arotomy. In this respect, we believe that laparoscopic staging sur-
gery for EOC is technically feasible if performed by veteran
surgeons. Nevertheless, the distinction between tumor rupture and
puncture was considered without details in most studies [10]. To
evaluate these outcomes adequately, future studies are necessitated
regarding techniques, and deﬁnitions need to be clearly deﬁned.
Fig. 3. A forest plot of the outcome comparisons between laparoscopy and laparotomy as a staging surgery: (A) operative time; (B) intraoperative blood loss; (C) pelvic lym-
phadenectomy number; (D) para-aortic lymphadenectomy number; (E) time to ﬁrst postoperative ﬂatus; (F) intraoperative complications; (G) postoperative complications; (H)
hospital stay; (I) recurrence rate; and (J) postoperative mortality rate. CI ¼ conﬁdence interval; MeH ¼ Mantel-Haenszel; SD ¼ standard deviation.
Y. Lu et al. / Taiwanese Journal of Obstetrics & Gynecology 54 (2015) 29e3834According to previous studies that compared the size of the
resected omental specimen in laparoscopy and laparotomy for
staging EOC, there were no signiﬁcant differences between the two
surgical methods [29,30]. These ﬁndings were similar to ourincluded studies. For example, Park et al [2] found no signiﬁcant
differences in resected omental specimens between the two groups
[laparoscopy/laparotomy: (186 ± 178)/(347 ± 378)], and Chi et al
[24] also observed similar results [laparoscopy/laparotomy:
Fig. 3. (continued).
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Fig. 3. (continued).
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hospital stay in seven included studies, and there was a signiﬁcant
difference between the two groups [MD ¼ 4.87; 95% CI
(7.26, 2.47); p < 0.0001]. Reduced hospital stays were observed
in the laparoscopy group that was similar to another quantitative
analysis involving 11 observational studies [12]. We also analyzed
the time to ﬁrst postoperative ﬂatus in nine included studies and
found a reduced time to ﬁrst postoperative ﬂatus in the laparoscopygroup [MD ¼ 1.28; 95% CI (1.72, 0.83); p < 0.00001]. These
ﬁndings all suggest that laparoscopic staging surgery could be
compatible with laparotomy for female patients with EOC.
Laparoscopic staging surgery for ovarian cancer can be associ-
ated with numerous complications including umbilical hernias,
retroperitoneal hematomas, vascular injury, lymphocele, obturator
nerve damage, bowel injury or obstruction, and ureter injury
[9]. Hua et al [31] reported signiﬁcantly fewer postoperative
Fig. 4. A funnel chart showing operative time of the 11 included trials. MD ¼ mean
difference; SE ¼ standard error.
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view of our data analysis, however, we found no signiﬁcant dif-
ferences in intraoperative complications [OR ¼ 1.34; 95% CI (0.37,
4.93); p ¼ 0.66] or postoperative complications [OR ¼ 0.26; 95% CI
(0.13, 0.52); p ¼ 0.0001] between laparoscopy and laparotomy.
Thus, laparoscopy was at least equivalent to, although not better
than, laparotomy for staging surgery regarding complications.
It has been reported that a laparotomy approach for epithelial-
origin EOC alone had a recurrence rate of at least 20% after sufﬁ-
cient follow-up in RCTs [32,33]. We analyzed the recurrence rate
during the follow-up period after staging surgery in seven included
studies, and a reduced recurrence rate was observed in the lapa-
roscopy group. The difference between the two groups was sig-
niﬁcant [OR ¼ 0.32; 95% CI (0.13, 0.82); p ¼ 0.02]. However, data in
our study not only contained the epithelial-origin histological type,
but also included other pathological patterns such as sex corde-
stromal, germ cell tumors, and carcinosarcoma ovarian cancer. In
addition, we also analyzed the postoperative death rate during the
follow-up period after staging surgery in four included studies, and
found no signiﬁcant difference between the two groups [OR¼ 0.47;
95% CI (0.09, 2.59); p ¼ 0.83]. Therefore, the survival data used to
deﬁne the mortality rate of patients with gynecological malig-
nancies whowere managed by laparoscopy might be insufﬁcient. A
major barrier to conducting RCTs for EOC might be the difﬁculty in
recruiting a sufﬁcient number of participants. However, we believe
our ﬁndings suggest that laparoscopic staging surgery is a safe
approach as laparotomy is for EOC patients.
The proportion of upstaging postoperation could be a parameter
for the performance of appropriate radical procedures [12]. Three of
our included studieshadupstaging after the staging surgerybecause
of intraoperative tumor rupture. Intraoperative tumor rupture was
one of the safety concerns of laparoscopic staging surgery and was
controversial. Tumor rupture during staging surgerymight increase
the chance of postoperative adjuvant therapy, but until now, no
evidencewas available to conﬁrm that intraoperative tumor rupture
contributed to a poor prognosis [34]. Furthermore, a similar intra-
operative tumor rupture rate (11.4e30.3%) existed between lapa-
roscopy and laparotomy for staging surgery, but with no signiﬁcant
difference [28,35]. One of our included studies also demonstrated asimilar intraoperative tumor rupture rate (laparoscopy/laparotomy:
10.5/12.1%; p ¼ 1.00) [2], and another study even demonstrated a
lower intraoperative tumor rupture rate in laparoscopic staging
surgery (laparoscopy/laparotomy: 0/14.9%; p ¼ 0.037).4 Port-site
metastasis was another serious complication of laparoscopy in pa-
tients with ovarian cancer, but it had a rate of 0e2.3% that was
similar to laparotomy for staging surgery in the reports; moreover,
port-site metastasis was often observed in advanced ovarian cancer
[36,37]. In addition, it was reported that port-site metastasis could
bepreventedbycareful Endobaghandling during specimen removal
[38].
Our study had a few limitations. First, insufﬁcient data were
available to evaluate the safety of comprehensive staging surgery
for EOC, and the clinical outcomes were different in our included
studies that might have affected our meta-analysis. Second, all the
included studies were nonrandomized controlled studies that
inevitably reduced the quality of the pooled data. Third, we could
not assess the quality of life for women undergoing laparoscopy
compared with laparotomy because of the limited available litera-
ture, but one included study did report signiﬁcantly lower post-
operative pain scores in the laparoscopy group [4]. Lastly, only a few
of our included studies reported postoperative recurrence rates,
mortality rates, and disease-free survival, so a long-term curative
effect could not be evaluated in our study. Therefore, multicenter
RCTs or well-designed prospective studies with a large number of
participants and long follow-up periods are necessary to conﬁrm
the efﬁcacy and safety of laparoscopic staging surgery for EOC.Conclusion
The present meta-analysis indicated that the curative effect of
laparoscopic comprehensive staging surgery was equivalent to or
even better than that of conventional laparotomy for staging EOC.
More robust evidence is necessary to conﬁrm the efﬁcacy and
safety of laparoscopic comprehensive staging surgery for EOC.Conﬂicts of interest
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